CN105233031A - Traditional Chinese composition for treating bone trauma osteomyelitis - Google Patents

Traditional Chinese composition for treating bone trauma osteomyelitis Download PDF

Info

Publication number
CN105233031A
CN105233031A CN201510688291.2A CN201510688291A CN105233031A CN 105233031 A CN105233031 A CN 105233031A CN 201510688291 A CN201510688291 A CN 201510688291A CN 105233031 A CN105233031 A CN 105233031A
Authority
CN
China
Prior art keywords
traditional chinese
radix
chinese composition
effect
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510688291.2A
Other languages
Chinese (zh)
Inventor
吴瑞现
丁红梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510688291.2A priority Critical patent/CN105233031A/en
Publication of CN105233031A publication Critical patent/CN105233031A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese composition for treating bone trauma osteomyelitis. The traditional Chinese composition has the following technical scheme that the traditional Chinese composition is prepared from the following components in proportion by weight in the recipe: 10g of acanthopanax senticosus, 10g of atractylodes macrocephala, 10g of liquorice, 10g of angelica sinensis, 15g of radix paeoniae alba, 15g of fructus lycii, 15g of fructus ligustri lucidi, 15g of sticky rice, 40g of eupolyphaga, 30g of dangshen, 35g of carthamus tinctorius, 25g of angelica dahurica, 20g of polygonatum sibiricum, 60g of lonicera japonica, 20g of viola philippica, 20g of gymnema sylvestre schult, 20g of heartleaf houttuynia herb, 5g of ginkgo leaves and 5g of breviscapine. The treatment is performed on the basis of improving the human body immunity and enhancing the microcirculation. The traditional Chinese composition has the advantages that the traditional Chinese composition fast takes an effect; the treatment course is short; the pain of a patient is reduced; and the treatment effect is good, and the like.

Description

One treats the myelitic Chinese medicine composition of bone wound
[technical field]
The present invention relates to technical field of Chinese medicine, be specifically related to one and treat the myelitic Chinese medicine composition of bone wound.
[background technology]
Osteomyelitis is a kind of infection and destruction of bone, can by aerobic or anaerobe, and mycobacteria and fungus cause.Osteomyelitis is apt to occur in long bone, the foot of diabetics or the penetrance bone injury site caused due to wound or operation.It is that a kind of suppurative bacterium infects bone marrow, cortical bone and periosteum and the diseases associated with inflammation that causes, is mostly caused by haematogenous, is also manyly caused by wound or postoperative infection, how enters blood by the suppuration bacterium of furuncle carbuncle or other focuses and reaches osseous tissue.Bones of limbs two ends are subject to invade most, are the most common especially with hip joint.Common clinically have recurrent exerbation, has a strong impact on physical and mental health and work capacity.High heat, local pain during acute osteomyelitis onset, have diabrosis, suppurate, have sequestrum or cavity to be formed when transferring chronic osteomyelitis to.The normal threat to life of patient with severe symptoms, sometimes has to take the emergency approach of amputation, causes patient's lifelong disability.And along with the development of society, also there is huge change in the vehicles of people, automobiles etc. the easily vehicles also enter huge numbers of families, and the complicated fracture thus after traffic accident occurs but happens occasionally, and the thing followed is soft tissue injury and there is high infection risk.Traditional treatment Traumatic osteomyelitis treatment of infection pattern is focal cleaning use in conjunction antibiotic, but these class methods easily form drug resistance at therapeutic process, and while degerm, also eliminates the beneficial cells of part to human body simultaneously.And over the course for the treatment of, long medication causes the health of sufferer more and more weaker, be both unfavorable for treatment, and also extended treatment time and increased the weight of the misery of sufferer.Therefore how on the basis of improving autoimmunity, to be regulated by self microcirculation and Drug therapy two combines, be the problem to be solved in the present invention.
[summary of the invention]
The object of the invention is to the defect for prior art and deficiency, there is provided a kind of structure simple, one reasonable in design, easy to use treats the myelitic Chinese medicine composition of bone wound, it is treated at raising body immunity and increasing on microcirculatory basis, has instant effect, short treating period, alleviates the advantages such as the painful and therapeutic effect of sufferer is good.
One of the present invention treats the myelitic Chinese medicine composition of bone wound, and it adopts following technical scheme, and its formula forms by mass ratio as follows:
Radix Et Caulis Acanthopanacis Senticosi 10g, Rhizoma Atractylodis Macrocephalae 10g, Radix Glycyrrhizae 10g, Radix Angelicae Sinensis 10g, Radix Paeoniae Alba 15g, Fructus Lycii 15g, Fructus Ligustri Lucidi 15g, Oryza glutinosa 15g, eupolyphaga 40g, Radix Codonopsis 30g, Flos Carthami 35g, Radix Angelicae Dahuricae 25g, Rhizoma Polygonati 20g, Flos Lonicerae 60g, Herba Violae 20g, Radix Gymnematis Sylvestris 20g, Herba Houttuyniae 20g, Folium Ginkgo 5g, breviscapine 5g.
The pharmacological action of Chinese medicine of the present invention is as follows:
(1) Radix Et Caulis Acanthopanacis Senticosi: enhancing body, to the opposing of nonspecific stimulation and adaptive capacity, has antifatigue effect, has Detoxication, has analgesia, antipyretic, antiinflammatory action, also has significantly antipyretic, analgesic activity simultaneously.
(2) Rhizoma Atractylodis Macrocephalae: there is diuresis, hypoglycemic activity, have strengthening the spleen and stomach, strong health and improve the effect of resistance against diseases.
(3) Radix Glycyrrhizae: property is put down, sweet in the mouth, has removing toxic substances, eliminates the phlegm, pain relieving, spasmolytic is so that the pharmacological action such as anticancer.In the traditional Chinese medical science, Radix Glycyrrhizae invigorating the spleen and replenishing QI, grows and coughs lung moistening, and emergency is detoxified, and is in harmonious proportion hundred medicines.
(4) Radix Angelicae Sinensis: enrich blood, invigorate blood circulation, regulating menstruation, pain relieving, intestine moistening can be used for treating menoxenia, dysmenorrhea, pain caused by congestion, anemia, because of the constipation etc. caused by blood deficiency.
(5) Radix Paeoniae Alba: mainly antibacterial pain relieving, can depressed liver-energy dispersing and QI regulating, easing the affected liver nourish blood, slow in pain relieving, the effect of suppressing the hyperactive liver yin fluid astringing.
(6) Fructus Lycii: Fructus Lycii sweet in the mouth, property is put down.Mainly return liver, kidney, lung meridian.It is sweet fill and, matter moistens many liquid, enter kidney can beneficial essence to fill marrow supporing yang; Walk liver to enrich blood improving eyesight; Returning lung with nourishing the lung to arrest cough, is Yin-nourishing and Yang-supporting, the good medicine that beneficial essence is enriched blood.
(7) Fructus Ligustri Lucidi: property is put down, and sweet in the mouth, enters liver, kidney channel.There is nourishing the liver and kidney, the effect of improving eyesight black hair.
(8) Oryza glutinosa: nature and flavor are sweet, temperature.Enter spleen, stomach, lung meridian, invigorating the spleen and replenishing QI, control frequent micturition of quenching one's thirst, spontaneous perspiration, just let out
(9) eupolyphaga: become, tremble with fear.Slightly poisonous.Return Liver Channel.Effect: removing blood stasis, reunion of fractured tendons and bones.
(10) Radix Codonopsis: bitter, is slightly cold, enters the heart, Liver Channel; Effect: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, clear away heart-fire relieving restlessness, nourishing blood to tranquillize the mind.
(11) Flos Carthami: pungent, warm.GUIXIN, Liver Channel.
(12) Radix Angelicae Dahuricae: pungent, warm.Return lung, stomach, large intestine channel.Effect: the cold expelling that induces sweat, wind-expelling pain-stopping, clearing the nasal passage, dampness leukorrhagia stopping, detumescence and apocenosis.
(13) Rhizoma Polygonati: Rhizoma Polygonati has effect of invigorating the spleen and benefiting QI.
(14) Flos Lonicerae: sweet, cold.Return lung, the heart, stomach warp.Effect: heat-clearing and toxic substances removing, dispelling wind and heat pathogens.
(15) Herba Violae: bitter, acrid, cold.GUIXIN, Liver Channel.Effect: heat-clearing and toxic substances removing, removing heat from blood is subsided a swelling.
(16) Radix Gymnematis Sylvestris: nature and flavor are put down; Bitter; GUIXIN, liver, spleen channel; Function is clearing away heat and cooling blood; Evacuation of pus is subsided a swelling; Pain relieving granulation promoting.Main air pain of dampness syndrome; Laryngopharynx swelling and pain; Scrofula; Acute mastitis; Furuncle; Eczema; Innominate toxic swelling; Venom.
(17) Herba Houttuyniae: cold in nature, bitter in the mouth is pungent, enters liver, lung two warp, heat-clearing and toxic substances removing, inducing diuresis to remove edema.Control pneumonia, lung abscess, hematodiarrhoea, malaria, edema, gonorrhea, leucorrhea, carbuncle, hemorrhoid, proctoptosis, eczema, tinea alba, scabies.
(18) Folium Ginkgo: containing the multiple components that the healths such as natural activity flavone and amarolide are useful, there is dissolving cholesterol, the effect of blood vessel dilating, has positive effect to improving disordered brain function, arteriosclerosis, hypertension, dizzy, tinnitus, headache, senile dementia, hypomnesis etc.
(19) breviscapine: be the flavonoids effective constituent extracted from feverfew Herba Erigerontis is the mixture of Herba Erigerontis A prime and lamp-dish flower acetic, based on lamp-dish flower acetic.For the loose block of yellow; Significantly can improve cerebral circulation, increase cerebral blood flow, antagonism lobus posterior hypophyseos causes hypoxic-ischemic, suppresses platelet aggregation, reduces blood fat and blood viscosity, fibrinolysis enhancing, anti-blood.
After adopting said structure, beneficial effect of the present invention is: one of the present invention treats the myelitic Chinese medicine composition of bone wound, it is treated at raising body immunity and increasing on microcirculatory basis, has instant effect, short treating period, alleviates the advantages such as the painful and therapeutic effect of sufferer is good.
[detailed description of the invention]
Describe the present invention in detail with specific embodiment below, illustrative examples wherein and explanation are only used for explaining the present invention, but not as a limitation of the invention.
One described in this detailed description of the invention treats the myelitic Chinese medicine composition of bone wound, and it adopts following technical scheme, and its formula forms by mass ratio as follows:
Radix Et Caulis Acanthopanacis Senticosi 10g, Rhizoma Atractylodis Macrocephalae 10g, Radix Glycyrrhizae 10g, Radix Angelicae Sinensis 10g, Radix Paeoniae Alba 15g, Fructus Lycii 15g, Fructus Ligustri Lucidi 15g, Oryza glutinosa 15g, eupolyphaga 40g, Radix Codonopsis 30g, Flos Carthami 35g, Radix Angelicae Dahuricae 25g, Rhizoma Polygonati 20g, Flos Lonicerae 60g, Herba Violae 20g, Radix Gymnematis Sylvestris 20g, Herba Houttuyniae 20g, Folium Ginkgo 5g, breviscapine 5g.
The present invention adopts following preparation method: get above-mentioned raw materials: Radix Et Caulis Acanthopanacis Senticosi 10g, Rhizoma Atractylodis Macrocephalae 10g, Radix Glycyrrhizae 10g, Radix Angelicae Sinensis 10g, Radix Paeoniae Alba 15g, Fructus Lycii 15g, Fructus Ligustri Lucidi 15g, Oryza glutinosa 15g, eupolyphaga 40g, Radix Codonopsis 30g, Flos Carthami 35g, Radix Angelicae Dahuricae 25g, Rhizoma Polygonati 20g, Flos Lonicerae 60g, Herba Violae 20g, Radix Gymnematis Sylvestris 20g, Herba Houttuyniae 20g, Folium Ginkgo 5g and breviscapine 5g, grind, sieve, be placed in blender, stir, then add appropriate water and carry out mix homogeneously, under being coated on affected part outward, once a day, within 2 months, be a course for the treatment of.
In the present invention, Radix Et Caulis Acanthopanacis Senticosi, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Fructus Lycii etc. have the function improving body immunity, thus the basis of raising body immunity is treated, and ensure that sufferer is treated in stronger body constitution, improve curative effect.Folium Ginkgo 5g and breviscapine 5g in the present invention, permeates and have the microcirculatory effect of adjustment human body in human body, improve therapeutic effect, alleviate the pain of sufferer fast.
The present invention's Chinese medicine of the present invention is prepared according to traditional Chinese medical science mechanism, there is promoting blood circulation to remove blood stasis, the routed evacuation of pus that disappears, continuous effect that muscle is good for bone, antiinflammatory is invigorated blood circulation, the new bone of growth-promoting, beneficial marrow add essence, granulation promoting tissue regeneration promoting, have no side effect, take effect obviously, short treating period, has good therapeutic effect to osteomyelitis.
The above is only better embodiment of the present invention, therefore all equivalences done according to structure, feature and the principle described in patent claim of the present invention change or modify, and are included in patent claim of the present invention.

Claims (1)

1. the myelitic Chinese medicine composition for the treatment of bone wound, it is characterized in that: it adopts following technical scheme, its formula forms by mass ratio as follows: Radix Et Caulis Acanthopanacis Senticosi 10g, Rhizoma Atractylodis Macrocephalae 10g, Radix Glycyrrhizae 10g, Radix Angelicae Sinensis 10g, Radix Paeoniae Alba 15g, Fructus Lycii 15g, Fructus Ligustri Lucidi 15g, Oryza glutinosa 15g, eupolyphaga 40g, Radix Codonopsis 30g, Flos Carthami 35g, Radix Angelicae Dahuricae 25g, Rhizoma Polygonati 20g, Flos Lonicerae 60g, Herba Violae 20g, Radix Gymnematis Sylvestris 20g, Herba Houttuyniae 20g, Folium Ginkgo 5g, breviscapine 5g.
CN201510688291.2A 2015-10-20 2015-10-20 Traditional Chinese composition for treating bone trauma osteomyelitis Pending CN105233031A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510688291.2A CN105233031A (en) 2015-10-20 2015-10-20 Traditional Chinese composition for treating bone trauma osteomyelitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510688291.2A CN105233031A (en) 2015-10-20 2015-10-20 Traditional Chinese composition for treating bone trauma osteomyelitis

Publications (1)

Publication Number Publication Date
CN105233031A true CN105233031A (en) 2016-01-13

Family

ID=55031024

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510688291.2A Pending CN105233031A (en) 2015-10-20 2015-10-20 Traditional Chinese composition for treating bone trauma osteomyelitis

Country Status (1)

Country Link
CN (1) CN105233031A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085315A (en) * 2011-01-02 2011-06-08 江和训 Traditional Chinese medicine composition for treating acute and chronic osteomyelitis
CN103432297A (en) * 2013-08-01 2013-12-11 焦敏 Traditional Chinese medicine for treating osteomyelitis
CN104189643A (en) * 2014-09-09 2014-12-10 郑州中医骨伤病医院 Osteopathia rehabilitation pill for treating chronic osteomyelitis
CN104606532A (en) * 2014-12-29 2015-05-13 徐立新 Traditional Chinese medicine formula for treating osteomyelitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085315A (en) * 2011-01-02 2011-06-08 江和训 Traditional Chinese medicine composition for treating acute and chronic osteomyelitis
CN103432297A (en) * 2013-08-01 2013-12-11 焦敏 Traditional Chinese medicine for treating osteomyelitis
CN104189643A (en) * 2014-09-09 2014-12-10 郑州中医骨伤病医院 Osteopathia rehabilitation pill for treating chronic osteomyelitis
CN104606532A (en) * 2014-12-29 2015-05-13 徐立新 Traditional Chinese medicine formula for treating osteomyelitis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
南京中医药大学: "《中药大辞典》", 30 June 2014 *
卿茂盛: ""中西医结合治疗慢性骨髓炎32例体会"", 《湖南中医学院学报》 *
唐镜波: "《452种注射剂安全应用与配伍》", 31 January 2014 *

Similar Documents

Publication Publication Date Title
CN103536758B (en) Traditional Chinese medicinal composition for treating night sweat due to yin deficiency
CN105412650A (en) Medicine for treating dermatophytosis
CN103417742A (en) Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia
CN102988639B (en) Medicament for treating cervical spondylosis and preparation method of medicament
CN106668631A (en) Chinese herbal medicine for treating rhinitis
CN104623232A (en) Traditional Chinese medicine composition for treating tinnitus
CN103784824A (en) Chinese herbal preparation for treating lumbar disc herniation and rheumatoid
CN103495103B (en) Medicament for promoting digestion and strengthening spleen
CN103705833B (en) One treats prosopalgic Chinese medicine
CN112972557A (en) Medicinal liquor for treating arthralgia and myalgia and preparation method thereof
CN106620471A (en) Traditional Chinese medicine composition for postoperative rehabilitation of bone fracture
CN105561270A (en) Analgesic Chinese herbal medicine for external application and preparation method thereof
CN105079515A (en) Traditional Chinese medicine composition for treating post-traumatic headache
CN1814218A (en) Hormone external-dressing agent for treating dermatitis
CN105233031A (en) Traditional Chinese composition for treating bone trauma osteomyelitis
CN103736013B (en) One treats phthisical Chinese medicine
CN103330814A (en) Traditional Chinese medicine composition for treating deficiency of kidney yang
CN101912488A (en) Chinese medicinal herb for treating hypomenorrhea
CN102366591B (en) Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method
CN101940773A (en) Chinese medicinal herb for treating chronic bronchitis
CN103028086B (en) Traditional Chinese medicine pill for treating iron deficiency anemia
CN106618032A (en) Health care medicine pillow
CN106074992A (en) A kind of medical herbs for oral administration treating chest traumatic injury wound and using method thereof
CN105079425A (en) Composition preparation for treating infantile hand-foot-mouth disease, and preparation method of composition preparation
CN105031181A (en) Medicinal liquor for treating rheumatic arthralgia and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160113